Combined treatment with endoscopic mitral valve repair and tafamidis in wild-type transthyretin cardiac amyloidosis and primary mitral regurgitation

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular and pulmonary 1 Intervention HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by